Basking Ridge, N.J., USA - July 20, 2009, Basking Ridge, N.J., USA - Regado Biosciences announced that its Medical Advisory Board (MAB) has three new members: John Eikelboom, Philippe Menasche and Lars Wallentin of Sweden.
Article continues below
Regado's Medical Advisory Board now has twelve members and those are: Robert A. Harrington, MD, (Chairman of the Medical Advisory Board), Professor of Medicine and Director, Duke Clinical Research Institute, Duke University, Durham, North Carolina; Paul W. Armstrong, MD, Professor of Medicine, Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada and Director of the Canadian VIGOUR Centre (Virtual Coordinating Centre for Global Collaborative Cardiovascular Research); Richard C. Becker, MD, Professor of Medicine and Director of the Cardiovascular Thrombosis Center, Duke Clinical Research Institute, Duke University, Durham, North Carolina; Robert M. Califf, MD, (Special Advisor to Regado Biosciences, Inc. and ex officio member of the Medical Advisory Board), Vice Chancellor for Clinical Research and Professor of Medicine, Division of Cardiology, Duke University Medical Center and Director, Duke Translational Medicine Institute, Duke University, Durham, North Carolina; John Eikelboom, MBBS, Associate Professor, McMaster University and Haematologist, Hamilton General Hospital, Hamilton, Ontario, Canada; Michael Gibson, MD, Associate Professor of Medicine and Chief, Clinical Research, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Harvard University, Boston, Massachusetts; Neal S. Kleiman, MD, Medical Director, Cardiac Catheterization Laboratories, The Methodist DeBakey Heart Center, The Methodist Hospital, Houston, Texas and Professor of Medicine, Weill Medical College, Cornell University; A. Michael Lincoff, MD, Director, Cleveland Clinic Coordinating Center for Clinical Research (C5Research); Director, Center for Clinical Research and Vice Chairman, Lerner Research Institute and Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio; Roxana Mehran, MD, Joint Chief Scientific Officer, Clinical Trial Center, Cardiovascular Research Foundation, New York, New York and Associate Professor of Medicine, Columbia University Medical Center, Columbia University, New York, New York; Philippe Menasche, MD, PhD, Professor of Thoracic and Cardiovascular Surgery, University of Paris Descartes and Chief of the Cardiac Surgery Unit, Hopital Europeen Georges Pompidou, Paris, France; Lars Wallentin, MD, PhD, Professor of Cardiology, Uppsala Clinical Research Centre, University Hospital, Uppsala, Sweden; and Harvey White, DSc, Honorary Clinical Professor of Medicine, University of Auckland and Director of Coronary Care and Green Lane Cardiovascular Research Unit, Auckland City Hospital, Auckland, New Zeal ■